1. Home
  2. ADMA vs FA Comparison

ADMA vs FA Comparison

Compare ADMA & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • FA
  • Stock Information
  • Founded
  • ADMA 2004
  • FA 2003
  • Country
  • ADMA United States
  • FA United States
  • Employees
  • ADMA N/A
  • FA N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • FA Business Services
  • Sector
  • ADMA Health Care
  • FA Consumer Discretionary
  • Exchange
  • ADMA Nasdaq
  • FA Nasdaq
  • Market Cap
  • ADMA 4.1B
  • FA 3.3B
  • IPO Year
  • ADMA N/A
  • FA 2021
  • Fundamental
  • Price
  • ADMA $17.89
  • FA $18.91
  • Analyst Decision
  • ADMA Strong Buy
  • FA Buy
  • Analyst Count
  • ADMA 4
  • FA 8
  • Target Price
  • ADMA $21.25
  • FA $20.80
  • AVG Volume (30 Days)
  • ADMA 2.6M
  • FA 918.0K
  • Earning Date
  • ADMA 02-26-2025
  • FA 11-12-2024
  • Dividend Yield
  • ADMA N/A
  • FA N/A
  • EPS Growth
  • ADMA N/A
  • FA N/A
  • EPS
  • ADMA 0.28
  • FA 0.03
  • Revenue
  • ADMA $382,809,000.00
  • FA $755,643,000.00
  • Revenue This Year
  • ADMA $66.84
  • FA $17.68
  • Revenue Next Year
  • ADMA $14.72
  • FA $81.35
  • P/E Ratio
  • ADMA $63.82
  • FA $550.30
  • Revenue Growth
  • ADMA 63.39
  • FA N/A
  • 52 Week Low
  • ADMA $4.37
  • FA $14.01
  • 52 Week High
  • ADMA $23.64
  • FA $20.79
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 42.39
  • FA 48.25
  • Support Level
  • ADMA $17.08
  • FA $18.22
  • Resistance Level
  • ADMA $18.97
  • FA $19.92
  • Average True Range (ATR)
  • ADMA 0.75
  • FA 0.50
  • MACD
  • ADMA -0.20
  • FA -0.13
  • Stochastic Oscillator
  • ADMA 27.81
  • FA 32.17

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About FA First Advantage Corporation

First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.

Share on Social Networks: